ADV HEALTHC MATER 润色咨询

Advanced Healthcare Materials

出版年份:暂无数据 年文章数:2779 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:6.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:Advanced Functional Materials转投Advanced Healthcare Materials,期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些?没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0<br>偏重的研究方向:生物材料<br>经验分享:2022-11-24投稿,2023-01-08收到审稿人意见,3个审稿人,都提出来宝贵的已经,目前已经修改完,准备明天发回去。希望能接受。我是一作,投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天,还是Manuscript Submitted,各位朋友有指点一下啥情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:纳米材料;抗肿瘤<br>经验分享:投稿14天还是显示Manuscript Submitted,投的是ADV HEALTHC MATER关于纳米材料的综述, 正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛,投稿10天一直Under consideration,是送审了吗,一审周期大约多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:21 apr 2018 投稿 <br> 24 may 2018 一审结果回来,小修;28号修回 <br> 28 may 2018 录用 <br> 审稿速度还可以,审稿人和编辑都很nice,很好的杂志。希望分数越来越高!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向:生物材料<br>经验分享:请问修回后为什么一直看不到稿件状态啊,已经两天了,求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062600, encodeId=6df7106260016, content=请问这个期刊一作是看不到状态的吗?通讯那边有显示,自己这边却全部显示0,这正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38165643258, createdName=ms1000001392557939, createdTime=Thu Oct 21 14:58:46 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2019-07-13 初衷45728bd7

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:Advanced Functional Materials转投Advanced Healthcare Materials,期待能中

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:Advanced Functional Materials转投Advanced Healthcare Materials,期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些?没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0<br>偏重的研究方向:生物材料<br>经验分享:2022-11-24投稿,2023-01-08收到审稿人意见,3个审稿人,都提出来宝贵的已经,目前已经修改完,准备明天发回去。希望能接受。我是一作,投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天,还是Manuscript Submitted,各位朋友有指点一下啥情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:纳米材料;抗肿瘤<br>经验分享:投稿14天还是显示Manuscript Submitted,投的是ADV HEALTHC MATER关于纳米材料的综述, 正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛,投稿10天一直Under consideration,是送审了吗,一审周期大约多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:21 apr 2018 投稿 <br> 24 may 2018 一审结果回来,小修;28号修回 <br> 28 may 2018 录用 <br> 审稿速度还可以,审稿人和编辑都很nice,很好的杂志。希望分数越来越高!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向:生物材料<br>经验分享:请问修回后为什么一直看不到稿件状态啊,已经两天了,求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062600, encodeId=6df7106260016, content=请问这个期刊一作是看不到状态的吗?通讯那边有显示,自己这边却全部显示0,这正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38165643258, createdName=ms1000001392557939, createdTime=Thu Oct 21 14:58:46 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2022-08-12 ms5000000105805022

    请问上传production data 都包括哪些?没有处理的数据

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:Advanced Functional Materials转投Advanced Healthcare Materials,期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些?没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0<br>偏重的研究方向:生物材料<br>经验分享:2022-11-24投稿,2023-01-08收到审稿人意见,3个审稿人,都提出来宝贵的已经,目前已经修改完,准备明天发回去。希望能接受。我是一作,投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天,还是Manuscript Submitted,各位朋友有指点一下啥情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:纳米材料;抗肿瘤<br>经验分享:投稿14天还是显示Manuscript Submitted,投的是ADV HEALTHC MATER关于纳米材料的综述, 正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛,投稿10天一直Under consideration,是送审了吗,一审周期大约多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:21 apr 2018 投稿 <br> 24 may 2018 一审结果回来,小修;28号修回 <br> 28 may 2018 录用 <br> 审稿速度还可以,审稿人和编辑都很nice,很好的杂志。希望分数越来越高!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向:生物材料<br>经验分享:请问修回后为什么一直看不到稿件状态啊,已经两天了,求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062600, encodeId=6df7106260016, content=请问这个期刊一作是看不到状态的吗?通讯那边有显示,自己这边却全部显示0,这正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38165643258, createdName=ms1000001392557939, createdTime=Thu Oct 21 14:58:46 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2023-01-30 jeremy7226 来自江苏省

    审稿速度:2.0
    偏重的研究方向:生物材料
    经验分享:2022-11-24投稿,2023-01-08收到审稿人意见,3个审稿人,都提出来宝贵的已经,目前已经修改完,准备明天发回去。希望能接受。我是一作,投稿后是看不到状态的。

    8

    展开8条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:Advanced Functional Materials转投Advanced Healthcare Materials,期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些?没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0<br>偏重的研究方向:生物材料<br>经验分享:2022-11-24投稿,2023-01-08收到审稿人意见,3个审稿人,都提出来宝贵的已经,目前已经修改完,准备明天发回去。希望能接受。我是一作,投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天,还是Manuscript Submitted,各位朋友有指点一下啥情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:纳米材料;抗肿瘤<br>经验分享:投稿14天还是显示Manuscript Submitted,投的是ADV HEALTHC MATER关于纳米材料的综述, 正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛,投稿10天一直Under consideration,是送审了吗,一审周期大约多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:21 apr 2018 投稿 <br> 24 may 2018 一审结果回来,小修;28号修回 <br> 28 may 2018 录用 <br> 审稿速度还可以,审稿人和编辑都很nice,很好的杂志。希望分数越来越高!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向:生物材料<br>经验分享:请问修回后为什么一直看不到稿件状态啊,已经两天了,求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062600, encodeId=6df7106260016, content=请问这个期刊一作是看不到状态的吗?通讯那边有显示,自己这边却全部显示0,这正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38165643258, createdName=ms1000001392557939, createdTime=Thu Oct 21 14:58:46 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2022-06-04 王璐璐

    投稿5天,还是Manuscript Submitted,各位朋友有指点一下啥情况?

    9

    展开9条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:Advanced Functional Materials转投Advanced Healthcare Materials,期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些?没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0<br>偏重的研究方向:生物材料<br>经验分享:2022-11-24投稿,2023-01-08收到审稿人意见,3个审稿人,都提出来宝贵的已经,目前已经修改完,准备明天发回去。希望能接受。我是一作,投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天,还是Manuscript Submitted,各位朋友有指点一下啥情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:纳米材料;抗肿瘤<br>经验分享:投稿14天还是显示Manuscript Submitted,投的是ADV HEALTHC MATER关于纳米材料的综述, 正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛,投稿10天一直Under consideration,是送审了吗,一审周期大约多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:21 apr 2018 投稿 <br> 24 may 2018 一审结果回来,小修;28号修回 <br> 28 may 2018 录用 <br> 审稿速度还可以,审稿人和编辑都很nice,很好的杂志。希望分数越来越高!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向:生物材料<br>经验分享:请问修回后为什么一直看不到稿件状态啊,已经两天了,求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062600, encodeId=6df7106260016, content=请问这个期刊一作是看不到状态的吗?通讯那边有显示,自己这边却全部显示0,这正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38165643258, createdName=ms1000001392557939, createdTime=Thu Oct 21 14:58:46 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2023-05-24 ms5000000742771461 来自山东省

    审稿速度:1.0 | 投稿命中率:95.0
    偏重的研究方向:纳米材料;抗肿瘤
    经验分享:投稿14天还是显示Manuscript Submitted,投的是ADV HEALTHC MATER关于纳米材料的综述, 正常吗

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:Advanced Functional Materials转投Advanced Healthcare Materials,期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些?没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0<br>偏重的研究方向:生物材料<br>经验分享:2022-11-24投稿,2023-01-08收到审稿人意见,3个审稿人,都提出来宝贵的已经,目前已经修改完,准备明天发回去。希望能接受。我是一作,投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天,还是Manuscript Submitted,各位朋友有指点一下啥情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:纳米材料;抗肿瘤<br>经验分享:投稿14天还是显示Manuscript Submitted,投的是ADV HEALTHC MATER关于纳米材料的综述, 正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛,投稿10天一直Under consideration,是送审了吗,一审周期大约多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:21 apr 2018 投稿 <br> 24 may 2018 一审结果回来,小修;28号修回 <br> 28 may 2018 录用 <br> 审稿速度还可以,审稿人和编辑都很nice,很好的杂志。希望分数越来越高!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向:生物材料<br>经验分享:请问修回后为什么一直看不到稿件状态啊,已经两天了,求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062600, encodeId=6df7106260016, content=请问这个期刊一作是看不到状态的吗?通讯那边有显示,自己这边却全部显示0,这正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38165643258, createdName=ms1000001392557939, createdTime=Thu Oct 21 14:58:46 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2020-02-26 玉水清澈

    各位大牛,投稿10天一直Under consideration,是送审了吗,一审周期大约多久?

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:Advanced Functional Materials转投Advanced Healthcare Materials,期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些?没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0<br>偏重的研究方向:生物材料<br>经验分享:2022-11-24投稿,2023-01-08收到审稿人意见,3个审稿人,都提出来宝贵的已经,目前已经修改完,准备明天发回去。希望能接受。我是一作,投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天,还是Manuscript Submitted,各位朋友有指点一下啥情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:纳米材料;抗肿瘤<br>经验分享:投稿14天还是显示Manuscript Submitted,投的是ADV HEALTHC MATER关于纳米材料的综述, 正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛,投稿10天一直Under consideration,是送审了吗,一审周期大约多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:21 apr 2018 投稿 <br> 24 may 2018 一审结果回来,小修;28号修回 <br> 28 may 2018 录用 <br> 审稿速度还可以,审稿人和编辑都很nice,很好的杂志。希望分数越来越高!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向:生物材料<br>经验分享:请问修回后为什么一直看不到稿件状态啊,已经两天了,求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062600, encodeId=6df7106260016, content=请问这个期刊一作是看不到状态的吗?通讯那边有显示,自己这边却全部显示0,这正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38165643258, createdName=ms1000001392557939, createdTime=Thu Oct 21 14:58:46 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2022-08-30 ms7000000605102289

    审稿速度:2.0 | 投稿命中率:95.0
    经验分享:666

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:Advanced Functional Materials转投Advanced Healthcare Materials,期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些?没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0<br>偏重的研究方向:生物材料<br>经验分享:2022-11-24投稿,2023-01-08收到审稿人意见,3个审稿人,都提出来宝贵的已经,目前已经修改完,准备明天发回去。希望能接受。我是一作,投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天,还是Manuscript Submitted,各位朋友有指点一下啥情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:纳米材料;抗肿瘤<br>经验分享:投稿14天还是显示Manuscript Submitted,投的是ADV HEALTHC MATER关于纳米材料的综述, 正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛,投稿10天一直Under consideration,是送审了吗,一审周期大约多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:21 apr 2018 投稿 <br> 24 may 2018 一审结果回来,小修;28号修回 <br> 28 may 2018 录用 <br> 审稿速度还可以,审稿人和编辑都很nice,很好的杂志。希望分数越来越高!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向:生物材料<br>经验分享:请问修回后为什么一直看不到稿件状态啊,已经两天了,求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062600, encodeId=6df7106260016, content=请问这个期刊一作是看不到状态的吗?通讯那边有显示,自己这边却全部显示0,这正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38165643258, createdName=ms1000001392557939, createdTime=Thu Oct 21 14:58:46 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2018-06-03 一大摞钱68a51aeb

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:21 apr 2018 投稿
    24 may 2018 一审结果回来,小修;28号修回
    28 may 2018 录用
    审稿速度还可以,审稿人和编辑都很nice,很好的杂志。希望分数越来越高!!!!

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:Advanced Functional Materials转投Advanced Healthcare Materials,期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些?没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0<br>偏重的研究方向:生物材料<br>经验分享:2022-11-24投稿,2023-01-08收到审稿人意见,3个审稿人,都提出来宝贵的已经,目前已经修改完,准备明天发回去。希望能接受。我是一作,投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天,还是Manuscript Submitted,各位朋友有指点一下啥情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:纳米材料;抗肿瘤<br>经验分享:投稿14天还是显示Manuscript Submitted,投的是ADV HEALTHC MATER关于纳米材料的综述, 正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛,投稿10天一直Under consideration,是送审了吗,一审周期大约多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:21 apr 2018 投稿 <br> 24 may 2018 一审结果回来,小修;28号修回 <br> 28 may 2018 录用 <br> 审稿速度还可以,审稿人和编辑都很nice,很好的杂志。希望分数越来越高!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向:生物材料<br>经验分享:请问修回后为什么一直看不到稿件状态啊,已经两天了,求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062600, encodeId=6df7106260016, content=请问这个期刊一作是看不到状态的吗?通讯那边有显示,自己这边却全部显示0,这正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38165643258, createdName=ms1000001392557939, createdTime=Thu Oct 21 14:58:46 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2022-06-22 ms4000000894908741

    偏重的研究方向:生物材料
    经验分享:请问修回后为什么一直看不到稿件状态啊,已经两天了,求解🙏🙏

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:Advanced Functional Materials转投Advanced Healthcare Materials,期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些?没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0<br>偏重的研究方向:生物材料<br>经验分享:2022-11-24投稿,2023-01-08收到审稿人意见,3个审稿人,都提出来宝贵的已经,目前已经修改完,准备明天发回去。希望能接受。我是一作,投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天,还是Manuscript Submitted,各位朋友有指点一下啥情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:纳米材料;抗肿瘤<br>经验分享:投稿14天还是显示Manuscript Submitted,投的是ADV HEALTHC MATER关于纳米材料的综述, 正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛,投稿10天一直Under consideration,是送审了吗,一审周期大约多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享:666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:21 apr 2018 投稿 <br> 24 may 2018 一审结果回来,小修;28号修回 <br> 28 may 2018 录用 <br> 审稿速度还可以,审稿人和编辑都很nice,很好的杂志。希望分数越来越高!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向:生物材料<br>经验分享:请问修回后为什么一直看不到稿件状态啊,已经两天了,求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062600, encodeId=6df7106260016, content=请问这个期刊一作是看不到状态的吗?通讯那边有显示,自己这边却全部显示0,这正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38165643258, createdName=ms1000001392557939, createdTime=Thu Oct 21 14:58:46 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2021-10-21 ms1000001392557939

    请问这个期刊一作是看不到状态的吗?通讯那边有显示,自己这边却全部显示0,这正常吗?

    1

    展开1条回复
共66条页码: 1/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分